Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Raghav

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Nature Medicine|July 31, 2025
Precemtabart tocentecan, an anti-CEACAM5 antibody-drug conjugate, in metastatic colorectal cancer: a phase 1 trialScott Kopetz, Valentina Boni, Ken Kato, et al.
Cancer|August 13, 2011
Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancersKanwal P S Raghav, Leonel F Hernandez-Aya, Xiudong Lei, et al.
The Oncologist|October 24, 2013
Impact of molecular alterations and targeted therapy in appendiceal adenocarcinomasKanwal P S Raghav, Aditya V Shetty, Syed M A Kazmi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2025
Advances in Targeting HER2 across Cancer Subtypes - A Pan-tumor ApproachTaiwo Adesoye, Ecaterina E Dumbrava, Kanwal P S Raghav, et al.
Cancer Medicine|June 11, 2020
Modified gemcitabine plus nab-paclitaxel regimen in advanced pancreatic ductal adenocarcinomaJane E Rogers, Jonathan D Mizrahi, Lianchun Xiao, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|January 15, 2020
Modified FOLFIRINOX in pancreatic cancer patients Age 75 or olderJonathan D Mizrahi, Jane E Rogers, Kenneth R Hess, et al.
JAMA Oncology|April 19, 2019
Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical TrialRachna T Shroff, Milind M Javle, Lianchun Xiao, et al.
British Journal of Cancer|August 14, 2019
Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinomaKrittiya Korphaisarn, Van Morris, Jenifer S Davis, et al.
Cancer|March 12, 2019
Clinical and molecular characterization of early-onset colorectal cancerAlexandra N Willauer, Yusha Liu, Allan A L Pereira, et al.
Ebiomedicine|October 11, 2020
CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligenceYue Zhao, Ziwei Pan, Sandeep Namburi, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Nature Medicine|July 31, 2025
Precemtabart tocentecan, an anti-CEACAM5 antibody-drug conjugate, in metastatic colorectal cancer: a phase 1 trialScott Kopetz, Valentina Boni, Ken Kato, et al.
Cancer|August 13, 2011
Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancersKanwal P S Raghav, Leonel F Hernandez-Aya, Xiudong Lei, et al.
The Oncologist|October 24, 2013
Impact of molecular alterations and targeted therapy in appendiceal adenocarcinomasKanwal P S Raghav, Aditya V Shetty, Syed M A Kazmi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2025
Advances in Targeting HER2 across Cancer Subtypes - A Pan-tumor ApproachTaiwo Adesoye, Ecaterina E Dumbrava, Kanwal P S Raghav, et al.
Cancer Medicine|June 11, 2020
Modified gemcitabine plus nab-paclitaxel regimen in advanced pancreatic ductal adenocarcinomaJane E Rogers, Jonathan D Mizrahi, Lianchun Xiao, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|January 15, 2020
Modified FOLFIRINOX in pancreatic cancer patients Age 75 or olderJonathan D Mizrahi, Jane E Rogers, Kenneth R Hess, et al.
JAMA Oncology|April 19, 2019
Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical TrialRachna T Shroff, Milind M Javle, Lianchun Xiao, et al.
British Journal of Cancer|August 14, 2019
Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinomaKrittiya Korphaisarn, Van Morris, Jenifer S Davis, et al.
Cancer|March 12, 2019
Clinical and molecular characterization of early-onset colorectal cancerAlexandra N Willauer, Yusha Liu, Allan A L Pereira, et al.
Ebiomedicine|October 11, 2020
CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligenceYue Zhao, Ziwei Pan, Sandeep Namburi, et al.
Pageof 5